Notch Therapeutics
Dr. Zúñiga-Pflücker recently discovered how to grow T cells—the building blocks of our immune systems—in a laboratory, using embryonic stem cells. The cell culture system developed by Ashton Trotman-Grant, Mahmood Mohtashami, and Dr. Zúñiga-Pflücker makes it possible to generate T cells in vitro from any source of stem cells. The system is creating many new research opportunities for immunologists, bringing them one step closer to creating designer T cells in vitro for cancer treatments and using in vitro T cells for the treatment of autoimmune disease.
This person is not in the org chart
This person is not in any offices
Notch Therapeutics
Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.